|Clarmin to acquire psychedelics firm Cybin in reverse takeover.Core One Labs completes acquisition of interest in Rejuva and Shahcor medical clinics.
ATAI Life Sciences acquires Kures to develop novel therapeutics for opioid abuse.
Mydecine Innovations signs definitive agreement to acquire Neuropharm.
|MagicMed Industries files provisional patent for psilocybin derivatives.
Source: Prohibition Partners UK